Clincosm LogoSign in Get a demo

nonalcoholic steatohepatitis

Showing 1 - 25 of 122
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nonalcoholic Steatohepatitis, Genetic Risk Factor Trial (ALN-PNP Dose Level 1, ALN-PNP Dose Level 2, ALN-PNP Dose Level 3)

Not yet recruiting
  • Nonalcoholic Steatohepatitis
  • Genetic Risk Factor
  • ALN-PNP Dose Level 1
  • +3 more
  • (no location specified)
Sep 5, 2023

Nonalcoholic Steatohepatitis Trial in Taipei (HUYPS-1 one tablet, HUYPS-1 nine tablets)

Completed
  • Nonalcoholic Steatohepatitis
  • HUYPS-1 one tablet
  • HUYPS-1 nine tablets
  • Taipei, Taiwan
    Tri-Service General Hospital
Aug 1, 2023

Non-Alcoholic Fatty Liver Disease, Type 2 Diabetes, Obesity Trial in United States (HU6, Placebo)

Not yet recruiting
  • Non-Alcoholic Fatty Liver Disease
  • +3 more
  • Montclair, California
  • +5 more
Jul 31, 2023

Non-alcoholic Fatty Liver Disease, Fatty Liver, Nonalcoholic, NAFLD Trial (Efinopegdutide, Semaglutide, Placebo)

Not yet recruiting
  • Non-alcoholic Fatty Liver Disease
  • +4 more
  • (no location specified)
May 17, 2023

Nonalcoholic Steatohepatitis Trial in Israel (5 mg/kg CM-101, Placebo)

Completed
  • Nonalcoholic Steatohepatitis
  • 5 mg/kg CM-101
  • Placebo
  • Be'er Sheva, Israel
  • +8 more
Apr 11, 2023

Nonalcoholic Steatohepatitis Trial in Worldwide (AZD2693, Placebo)

Recruiting
  • Nonalcoholic Steatohepatitis
  • Caba, Argentina
  • +117 more
Mar 30, 2023

Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis, Fatty Liver Trial in Boston (GE ultrasound system with increased

Not yet recruiting
  • Nonalcoholic Fatty Liver
  • +2 more
  • GE ultrasound system with increased acoustic output settings
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 19, 2023

Using Hydroxychloroquine to Treat Nonalcoholic Steatohepatitis

Recruiting
  • Nonalcoholic Steatohepatitis
  • Taipei, Taiwan
  • +1 more
Feb 8, 2023

Nonalcoholic Steatohepatitis Trial (Rosuvastatin 20 Mg Oral Tablet, Coenzyme Q10 100 MG Oral Capsule)

Not yet recruiting
  • Nonalcoholic Steatohepatitis
  • Rosuvastatin 20 Mg Oral Tablet
  • Coenzyme Q10 100 MG Oral Capsule
  • (no location specified)
Feb 7, 2023

Nonalcoholic Steatohepatitis With Advanced Fibrosis

Recruiting
  • Nonalcoholic Steatohepatitis
  • Standard of care
  • Richmond, Virginia
    Virginia Commonwealth University
Jan 31, 2023

Nonalcoholic Steatohepatitis Trial in Rochester (OA-235i (4 mg), OA-235i (8 mg), OA-235i Dose 3)

Recruiting
  • Nonalcoholic Steatohepatitis
  • OA-235i (4 mg)
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic
Jan 30, 2023

Non-alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis Trial in Argentina, Germany, United States (LYS006, LYS006 +

Terminated
Has Results
  • Non-alcoholic Fatty Liver Disease
  • Nonalcoholic Steatohepatitis
  • Coronado, California
  • +9 more
Jan 10, 2023

Nonalcoholic Steatohepatitis Trial in Worldwide (MK-3655, Placebo)

Active, not recruiting
  • Nonalcoholic Steatohepatitis
  • Tucson, Arizona
  • +179 more
Jan 19, 2023

Non-alcoholic Fatty Liver Disease, Fatty Liver, Nonalcoholic, NAFLD Trial in San Antonio (AZD7503 Intervention)

Active, not recruiting
  • Non-alcoholic Fatty Liver Disease
  • +5 more
  • AZD7503 Intervention
  • San Antonio, Texas
    Research Site
Jan 13, 2023

Nonalcoholic Steatohepatitis Trial in Glendale (B1344, Placebo)

Recruiting
  • Nonalcoholic Steatohepatitis
  • Glendale, California
    California Clinical Trials Medical Group, Inc.
Dec 8, 2022

Hepatocellular Carcinoma, Nonalcoholic Steatohepatitis Trial in Tarzana, New York, Durham (Lisinopril, Questionnaire

Recruiting
  • Hepatocellular Carcinoma
  • Nonalcoholic Steatohepatitis
  • Biospecimen Collection
  • +6 more
  • Los Angeles, California
  • +3 more
Dec 8, 2022

Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis Trial in Germany, Spain, United States

Recruiting
  • Nonalcoholic Fatty Liver
  • Nonalcoholic Steatohepatitis
    • Phoenix, Arizona
    • +73 more
    Nov 3, 2022

    Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis Trial in Worldwide (Efinopegdutide 20 mg/mL, Semaglutide 1.34

    Completed
    • Nonalcoholic Fatty Liver Disease
    • Nonalcoholic Steatohepatitis
    • Efinopegdutide 20 mg/mL
    • Semaglutide 1.34 mg/mL
    • Montclair, California
    • +68 more
    Nov 1, 2022

    Nonalcoholic Steatohepatitis Trial in Guangzhou (Dapagliflozin, Placebo)

    Recruiting
    • Nonalcoholic Steatohepatitis
    • Guangzhou, Guangdong, China
      Nanfang Hospital of Southern Medical University
    Oct 21, 2022

    Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis Trial in United States (d-alpha-tocopherol, Placebo)

    Recruiting
    • Nonalcoholic Fatty Liver Disease
    • Nonalcoholic Steatohepatitis
    • Vitamin E
    • Placebo
    • La Jolla, California
    • +8 more
    Oct 5, 2022

    Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis Trial in Yokohama (Experimental: 4 mg/day of WY-8678 (guanabenz acetate),

    Active, not recruiting
    • Nonalcoholic Fatty Liver
    • Nonalcoholic Steatohepatitis
    • Experimental: 4 mg/day of WY-8678 (guanabenz acetate)
    • Experimental: 8 mg/day of WY-8678 (guanabenz acetate)
    • Yokohama, Kanagawa, Japan
      Yokohama City University
    Sep 25, 2022

    NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes

    Active, not recruiting
    • Nonalcoholic Fatty Liver
    • +4 more
    • Transient Elastography
    • Boston, Massachusetts
      Joslin Diabetes Center
    Sep 16, 2022

    Nonalcoholic Steatohepatitis Trial in Worldwide (Tirzepatide, Placebo)

    Recruiting
    • Nonalcoholic Steatohepatitis
    • Birmingham, Alabama
    • +119 more
    Aug 17, 2022

    Nonalcoholic Steatohepatitis, NASH Trial in Worldwide (ALN-HSD, Placebo)

    Active, not recruiting
    • Nonalcoholic Steatohepatitis
    • NASH
    • Huntington Park, California
    • +20 more
    Aug 11, 2022

    Nonalcoholic Steatohepatitis Trial in Seoul (Placebo oral tablet, ALS-L1023 1,200mg, ALS-L1023 1,800mg)

    Completed
    • Nonalcoholic Steatohepatitis
    • Placebo oral tablet
    • +2 more
    • Seoul, Korea, Republic of
      Hanyang University Seoul Hospital
    Aug 9, 2022